DNA Microarray Market Trends, Size, Growth Drivers, Demand and Future Outlook
DNA Microarray Market Growth, Size, Trends Analysis - By Type, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Feb-2025 | Report ID: HLCA2565 | Pages: 1 - 234 | Formats*: |
| Category : Healthcare | |||
DNA Microarray Market Introduction and Overview
According to SPER Market Research, the Global DNA Microarray Market is estimated to reach USD 5.11 billion by 2034 with a CAGR of 9.09%.
The report includes an in-depth analysis of the Global DNA Microarray Market, including market size and trends, product mix, Applications, and supplier analysis. The rising incidence of cancer, improvements in software and information technologies, and the emergence of bioinformatics are all predicted to contribute to the growth of the global market. Furthermore, the expansion of research activities and the increasing application of DNA microarrays in gene expression investigations are propelling this market growth. Because diseases like cancer are becoming more common, advances in DNA microarray technology, such as higher-density arrays and multi-omics integration, are expected to increase genomic analysis and propel market expansion.
By Type: The oligonucleotide DNA microarrays segment leads the market and is expected to grow significantly due to their cost-effectiveness, ability to monitor gene expression across the genome, and increased market adoption. Their controlled hybridization specificity, especially for analyzing single nucleotide polymorphisms, drives demand. Meanwhile, the cDNA microarray segment is set for the fastest growth, driven by its widespread use in gene expression studies, polymorphism screening, genomic mapping, and gene discovery.
By Application: In 2024, the gene expression analysis segment dominated the market due to its extensive use in drug discovery, clinical diagnostics, microbiology, and other domains. Due to the advantages of DNA microarrays over other technologies and the increasing use of gene expression in drug development methods, demand for this technology has increased dramatically across a range of applications. The growing prevalence of targeted diseases, greater R&D spending for precision medicine, and strategic activities by market participants are all likely to support the genotyping segment's robust rise.
By End Use: The academic and research institutes segment led the market in 2024, driven by the growing use of microarrays in research and drug discovery. Meanwhile, diagnostic centers are expected to be the fastest-growing segment in the coming years, with diagnostic labs anticipated to increase demand for products used in diagnosing autoimmune diseases, cancers, infectious diseases, and other genetic mutation-related conditions.
By Regional Insights: North America dominated the DNA microarray market in 2024, accounting for the majority of revenue, owing to the presence of key industry companies and their increased efforts in creating improved DNA microarray products. Genomic advancements and access to cutting-edge research facilities are projected to generate major development prospects. Furthermore, increased usage of DNA microarray technology in research settings ranging from academic labs to biopharmaceutical corporations is accelerating the region's growth.
Market Competitive Landscape:
The market is highly consolidated. Some of the market key players are Agilent Technologies, Applied Micro Arrays, BIOMERIEUX, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, PerkinElmer, Inc., QIAGEN, Thermo Fisher Scientific, Inc., and others.
Recent Developments:
- In October 2024, Illumina Inc. introduced its MiSeq i100 Series of sequencing systems, designed to deliver exceptional speed and simplicity for benchtop next-generation sequencing (NGS). This new series aims to simplify genomic workflows, making high-quality sequencing more accessible to laboratories with reduced complexity.
- On March 14, 2023, Illumina Inc. unveiled its groundbreaking Illumina Complete Long Read technology, representing a major advancement in DNA sequencing. This technology powers the Illumina Complete Long Read Prep, Human, a high-performance long-read human whole-genome sequencing assay.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Type, By Application, By End Use. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Agilent Technologies, Applied Micro Arrays, BIOMERIEUX, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, PerkinElmer, Inc., QIAGEN, Thermo Fisher Scientific, Inc., and others. |
Key Topics Covered in the Report:
- Global DNA Microarray Market Size (FY’2021-FY’2034)
- Overview of Global DNA Microarray Market
- Segmentation of Global DNA Microarray Market By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays, Others)
- Segmentation of Global DNA Microarray Market By Application (Gene Expression Analysis, Genotyping, Others)
- Segmentation of Global DNA Microarray Market By End Use (Gene Expression Analysis, Genotyping, Others)
- Statistical Snap of Global DNA Microarray Market
- Expansion Analysis of Global DNA Microarray Market
- Problems and Obstacles in Global DNA Microarray Market
- Competitive Landscape in the Global DNA Microarray Market
- Details on Current Investment in Global DNA Microarray Market
- Competitive Analysis of Global DNA Microarray Market
- Prominent Players in the Global DNA Microarray Market
- SWOT Analysis of Global DNA Microarray Market
- Global DNA Microarray Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global DNA Microarray Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global DNA Microarray Market
7. Global DNA Microarray Market, By Type, (USD Million) 2021-2034
7.1. Complementary DNA Microarrays7.2. Oligonucleotide DNA Microarrays7.3. Others
8. Global DNA Microarray Market, By Application, (USD Million) 2021-2034
8.1. Gene Expression Analysis8.2. Genotyping8.3. Others
9. Global DNA Microarray Market, By End Use, (USD Million) 2021-2034
9.1. Gene Expression Analysis9.2. Genotyping9.3. Others
10. Global DNA Microarray Market, (USD Million) 2021-2034
10.1. Global DNA Microarray Market Size and Market Share
11. Global DNA Microarray Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia11.1.2. China11.1.3. India11.1.4. Japan11.1.5. South Korea11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France11.2.2. Germany11.2.3. Italy11.2.4. Spain11.2.5. United Kingdom11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia11.3.2. United Arab Emirates11.3.3. Qatar11.3.4. South Africa11.3.5. Egypt11.3.6. Morocco11.3.7. Nigeria11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada11.4.2. Mexico11.4.3. United States
11.5. Latin America
11.5.1. Argentina11.5.2. Brazil11.5.3. Rest of Latin America
12. Company Profile
12.1. Agilent Technologies
12.1.1. Company details12.1.2. Financial outlook12.1.3. Product summary12.1.4. Recent developments
12.2. Applied Micro Arrays
12.2.1. Company details12.2.2. Financial outlook12.2.3. Product summary12.2.4. Recent developments
12.3. BIOMERIEUX
12.3.1. Company details12.3.2. Financial outlook12.3.3. Product summary12.3.4. Recent developments
12.4. F. Hoffmann-La Roche Ltd.
12.4.1. Company details12.4.2. Financial outlook12.4.3. Product summary12.4.4. Recent developments
12.5. Illumina, Inc.
12.5.1. Company details12.5.2. Financial outlook12.5.3. Product summary12.5.4. Recent developments
12.6. Merck KGaA
12.6.1. Company details12.6.2. Financial outlook12.6.3. Product summary12.6.4. Recent developments
12.7. PerkinElmer, Inc.
12.7.1. Company details12.7.2. Financial outlook12.7.3. Product summary12.7.4. Recent developments
12.8. QIAGEN
12.8.1. Company details12.8.2. Financial outlook12.8.3. Product summary12.8.4. Recent developments
12.9. Thermo Fisher Scientific, Inc.
12.9.1. Company details12.9.2. Financial outlook12.9.3. Product summary12.9.4. Recent developments
12.10. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
DNA Microarray Market is projected to reach USD 5.11 billion by 2034, growing at a CAGR of 9.09% during the forecast period.
DNA Microarray Market grew in Market size from 2025. The Market is expected to reach USD 5.11 billion by 2034, at a CAGR of 9.09% during the forecast period.
DNA Microarray Market CAGR of 9.09% during the forecast period.
You can get the sample pages by clicking the link - Click Here
DNA Microarray Market size is USD 5.11 billion from 2025 to 2034.
DNA Microarray Market is covered By Type, By Application, By End Use.
The North America is anticipated to have the highest Market share in the DNA Microarray Market.
The key players in the Market include Companies Covered Agilent Technologies, Applied Micro Arrays, BIOMERIEUX, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, PerkinElmer, Inc., QIAGEN, Thermo Fisher Scientific, Inc., and others.
The rising incidence of cancer, improvements in software and information technologies, and the emergence of bioinformatics are all predicted to contribute to the growth of the global market.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
